<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31409738</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairment across ALS clinical stages in a population-based cohort.</ArticleTitle><Pagination><StartPage>e984</StartPage><EndPage>e994</EndPage><MedlinePgn>e984-e994</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000008063</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To assess the association of the degree of severity of motor impairment to that of cognitive impairment in a large cohort of patients with amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS">This is a population-based cross-sectional study on patients with ALS incident in Piemonte, Italy, between 2007 and 2015. Cognitive status was classified according to the revised ALS-FTD Consensus Criteria. The King system and the Milano Torino Staging system (MiToS) were used for defining the severity of motor impairment.</AbstractText><AbstractText Label="RESULTS">Of the 797 patients included in the study, 163 (20.5%) had ALS-frontotemporal dementia (FTD), 38 (4.8%) cognitive and behavioral impairment (ALScbi), 132 (16.6%) cognitive impairment (ALSci), 63 (7.9%) behavioral impairment (ALSbi), 16 (2.0%) nonexecutive impairment, and 385 (48.2%) were cognitively normal. According to King staging, the frequency of cases with ALS-FTD progressively increased from 16.5% in stage 1-44.4% in stage 4; conversely, the frequency of ALSci, ALSbi, and ALScbi increased from King stage 1 to King stage 3 and decreased thereafter. A similar pattern was observed with the MiToS staging. ALS-FTD was more frequent in patients with bulbar involvement at time of cognitive testing. Patients with <i>C9ORF72</i> expansion (n = 61) showed more severe cognitive impairment with increasing King and MiToS stages.</AbstractText><AbstractText Label="CONCLUSION">Our findings suggest that ALS motor and cognitive components may worsen in parallel, and that cognitive impairment becomes more pronounced when bulbar function is involved. Our data support the hypothesis that ALS pathology disseminates in a regional ordered sequence, through a cortico-efferent spreading model.</AbstractText><CopyrightInformation>&#xa9; 2019 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy. adriano.chio@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manera</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barberis</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrado</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alfonso</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bersano</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarnelli</LastName><ForeName>Maria Francesca</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solara</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zucchetti</LastName><ForeName>Jean Pierre</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peotta</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iazzolino</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the ALS Center (A. Chi&#xf2;, C.M., A. Canosa, U.M., R.V., M. Brunetti, M. Barberis, J.P.Z., L.P., B.I., A. Calvo), "Rita Levi Montalcini" Department of Neuroscience, University of Torino; Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino (A. Chi&#xf2;, C.M., A. Calvo), Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome; Department of Health Sciences Interdisciplinary Research Center of Autoimmune Diseases (L.C., S.D.), "Amedeo Avogadro" University of Eastern Piedmont; ALS Center (E.B., M.F.S., V.S., L.M.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carit&#xe0;, Novara; and Istituti Clinici Scientifici Maugeri (G.M.), IRCCS Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31409738</ArticleId><ArticleId IdType="pmc">PMC6745732</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000008063</ArticleId><ArticleId IdType="pii">WNL.0000000000008063</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. . Amyotrophic lateral sclerosis. Lancet 2017;390:2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Byrne S, et al. . Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590&#x2013;1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, et al. . Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh cognitive and behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 2018;19:387&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">29804470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilani M, Micallef J, Soubrouillard C, et al. . A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 2004;5:46&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">15204024</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, et al. . Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis: a longitudinal study in 52 patients. J Neurol 2005;252:772&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pubmed">15742104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Zydatiss K, Schuster C, et al. . No change in executive performance in ALS patients: a longitudinal neuropsychological study. Neurodegener Dis 2016;16:184&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">26613522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen-Hoerth C. Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurol Clin Pract 2017; 7:488&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800712</ArticleId><ArticleId IdType="pubmed">29431172</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, et al. . ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 2018;91:e1370-e1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. . Amyotrophic lateral sclerosis: frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:153&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM, et al. . A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2015;86:38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Moglia C, et al. . Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d'Aosta register. JAMA Neurol 2017;74:1097&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Grace J, Malloy P. Frontal Systems Behavior Scale (FrSBe): Professional Manual. Lutz, FL: Psychological Assessment Resources; 2001.</Citation></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, et al. . Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 2015;86:168&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons CJ, Mills RJ, Thornton EW, et al. . Rasch analysis of the Hospital Anxiety and Depression Scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes 2011;9:82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3192662</ArticleId><ArticleId IdType="pubmed">21955749</ArticleId></ArticleIdList></Reference><Reference><Citation>Iazzolino B, Pain D, Peotta L, et al. . Validation of the revised classification of cognitive and behavioural impairment in ALS. J Neurol Neurosurg Psychiatry 2019;90:734&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">30733331</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Elamin M, Bede P, et al. . The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012;83:102&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Jones A, Jivraj N, et al. . Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:279&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">24720420</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-Linked ALS-FTD. Neuron 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Grace GM, Freedman M, et al. . Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">19462523</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Santangelo G, Caiazzo G, et al. . Neuropsychological assessment in different King clinical stages of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2016;17:228&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">26905940</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SI, Park A, Kim HJ, et al. . Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations. PLoS One 2014;9:e87163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911969</ArticleId><ArticleId IdType="pubmed">24498297</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. . Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013;74:20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt R, de Reus MA, Scholtens LH, van den Berg LH, van den Heuvel MP. Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis. Neuroimage 2016;124:762&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pubmed">25869856</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthess I, Gorges M, M&#xfc;ller HP, et al. . Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis. Sci Rep 2016;6:38391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5144012</ArticleId><ArticleId IdType="pubmed">27929102</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Goldstein LH, Al-Chalabi A, et al. . Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1997;62:464&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC486852</ArticleId><ArticleId IdType="pubmed">9153602</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri A, Mento G, Calvo V, et al. . Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients. J Neurol Neurosurg Psychiatry 2015;86:574&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">25063584</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Irwin DJ, et al. . Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2014;127:423&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971993</ArticleId><ArticleId IdType="pubmed">24407427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">12370467</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T, Piguet O, Burrell JR, et al. . Predicting development of amyotrophic lateral sclerosis in frontotemporal dementia. J Alzheimers Dis 2017;58:163&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">28387671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley BJ, Petersen RC. Alzheimer's disease and mild cognitive impairment. Neurol Clin 2007;25:577&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682228</ArticleId><ArticleId IdType="pubmed">17659182</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004;62:506&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">14872045</ArticleId></ArticleIdList></Reference><Reference><Citation>Garre-Olmo J, Gen&#xed;s Batlle D, del Mar Fern&#xe1;ndez M, et al. . Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology 2010;75:1249&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pubmed">20810999</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2012;11:1006&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3507991</ArticleId><ArticleId IdType="pubmed">23079557</ArticleId></ArticleIdList></Reference><Reference><Citation>Placek K, Massimo L, Olm C, et al. . Cognitive reserve in frontotemporal degeneration: neuroanatomic and neuropsychological evidence. Neurology 2016;87:1813&#x2013;1819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089523</ArticleId><ArticleId IdType="pubmed">27683847</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, McMillan CT, Brettschneider J, et al. . Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2013;84:163&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3543474</ArticleId><ArticleId IdType="pubmed">23117491</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, Bittner V, Kasper E, et al. . Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neurosci 2014;15:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4086690</ArticleId><ArticleId IdType="pubmed">24981872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A. Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 2012;78:1085&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pubmed">22442427</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Atkins L, Leigh PN. Correlates of quality of life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Mot Neuron Disord 2002;3:123&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">12495573</ArticleId></ArticleIdList></Reference><Reference><Citation>Manes F, Torralva T, Ib&#xe1;&#xf1;ez A, Roca M, Bekinschtein T, Gleichgerrcht E. Decision-making in frontotemporal dementia: clinical, theoretical and legal implications. Dement Geriatr Cogn Disord 2011;32:11&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">21822019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoux M, Cova F, Pessiglione M, Hsu M, Dubois B, Bourgeois-Gironde S. Behavioral variant frontotemporal dementia patients do not succumb to the Allais paradox. Front Neurosci 2014;8:287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159974</ArticleId><ArticleId IdType="pubmed">25309311</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Vignola A, Mastro E, et al. . Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol 2010;17:1298&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pubmed">20402747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Hodges JR. Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients' behavioral changes than physical disability: a comparative study. BMC Neurol 2012;12:156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541170</ArticleId><ArticleId IdType="pubmed">23216745</ArticleId></ArticleIdList></Reference><Reference><Citation>Carelli L, Solca F, Faini A, et al. . Brain-computer interface for clinical purposes: cognitive assessment and rehabilitation. Biomed Res Int 2017;2017:1695290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5587953</ArticleId><ArticleId IdType="pubmed">28913349</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Carelli L, Solca F, et al. . An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol 2017;264:1136&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">28503706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>